Alexander S. Martin

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 280 citations · Full text

Factors Associated with Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

Alexander S. Martin, Daniel E. Abbott, Dennis J. Hanseman et al. · Annals of Surgical Oncology · 2016 · 33 citations

Cytoreductive Surgery, Surgical Oncology, Gastrointestinal Oncology +8

PACE: Analysis of acute toxicity in PACE-B, an international phase III randomized controlled trial comparing stereotactic body radiotherapy (SBRT) to conventionally fractionated or moderately hypofractionated external beam radiotherapy (CFMHRT) for localized prostate cancer (LPCa).

Nicholas John Van As, Douglas Brand, Alison Tree et al. · Journal of Clinical Oncology · 2019 · 29 citations

Acute Toxicity Severity, Radiation Medicine, Radiation Therapy +13

Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters

Tanachat Nilanon, Luciano Nocera, Alexander S. Martin et al. · JCO Clinical Cancer Informatics · 2020 · 22 citations · Full text